Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants

Significant liver fibrosis regression occurs after hepatitis C virus (HCV) therapy. However, the impact of direct-acting antivirals (DAAs) on steatosis is less clear. This study was aimed at evaluating serial fibrosis and steatosis alterations in patients with HCV genotype 1, who achieved sustained...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuaypen, Natthaya, Siripongsakun, Surachate, Hiranrat, Pantajaree, Tanpowpong, Natthaporn, Avihingsanon, Anchalee, Tangkijvanich, Pisit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191717/
https://www.ncbi.nlm.nih.gov/pubmed/35696400
http://dx.doi.org/10.1371/journal.pone.0269641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191717/
https://www.ncbi.nlm.nih.gov/pubmed/35696400
http://dx.doi.org/10.1371/journal.pone.0269641

Ejemplares similares